• 1
    Ariga T., Sekine M., Nakamura K., Igarashi M., Nagashima M., Miyatake T., Suzuki A., Yamakawa T. (1983) Isolation and characterization of a novel disialoganglioside containing N-glycolylneuraminic acid from pig skeletal muscle. J. Biochem. (Tokyo) 93 889893.
  • 2
    Beckman G., Beckman L., Ponten J., Westermark B. (1971) G-6-PD and PGM phenotypes of 16 continuous human tumor cell lines. Evidence against cross-contamination and contamination by HeLa cells. Hum. Hered. 21 238241.
  • 3
    Brigande J.V., Platt F.M., Seyfried T.N. (1998) Inhibition of glycosphingolipid biosynthesis does not impair growth or morphogenesis of the postimplantation mouse embryo. J. Neurochem. 70 871882.
  • 4
    Chou H.H., Takematsu H., Diaz S., Iber J., Nickerson E., Wright K.L., Muchmore E.A., Nelson D.L., Warren S.T., Varki A. (1998) A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc. Natl. Acad. Sci. USA 95 1175111756.
  • 5
    Cotterchio M. & Seyfried T.N. (1993) The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Mol. Chem. Neuropathol. 20 163172.
  • 6
    Cotterchio M. & Seyfried T.N. (1994) Serum gangliosides in mice with metastatic and non-metastatic brain tumors. J. Lipid Res. 35 1014.
  • 7
    Ecsedy J.A., Yohe H.C., Bergeron A.J., Seyfried T.N. (1998) Tumor-infiltrating macrophages contribute to the glycosphingolipid composition of brain tumors. J. Lipid Res. 39 22182227.
  • 8
    El-Abbadi M. & Seyfried T.N. (1994) Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol. 21 273285.
  • 9
    Flavin H.J., Wieraszko A., Seyfried T.N. (1991) Enhanced aspartate release from hippocampal slices of epileptic (El) mice. J. Neurochem. 56 10071011.
  • 10
    Folch J., Lees M., Sloane-Stanley G.H. (1957) A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 497509.
  • 11
    Fredman P. (1988) Gangliosides in human malignant gliomas, in New Trends in Ganglioside Research: Neurochemical and Neurogenerative Aspects (Ledeen R. W., Hogan E. L., Tettamanti G., Yates A., and Yu R. K., eds), pp. 151161. Liviana, Padova.
  • 12
    Fredman P., Mansson J.E., Bigner S.H., Wikstrand C.J., Bigner D.D., Svennerholm L. (1990) Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats. Biochim. Biophys. Acta 1045 239244.
  • 13
    Fredman P., Wikstrand C.J., Mansson J.E., Reifenberger G., Bigner S.H., Rasheed A., Svennerholm L., Bigner D.D. (1996) In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line. Glycoconj. J. 13 391399.
  • 14
    Furukawa K., Yamaguchi H., Oettgen H.F., Old L.J., Lloyd K.O. (1988) Analysis of the expression of N-glycolylneuraminic acid-containing gangliosides in cells and tissues using two human monoclonal antibodies. J. Biol. Chem. 263 1850718512.
  • 15
    Gura T. (1997) Systems for identifying new drugs are often faulty. Science 278 10411042.DOI: 10.1126/science.278.5340.1041
  • 16
    Hakomori S. (1996) Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res. 56 53095318.
  • 17
    Hamamoto T., Kurosawa N., Lee Y.C., Tsuji S. (1995) Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids. Biochim. Biophys. Acta 1244 223228.
  • 18
    Higa H.H. & Paulson J.C. (1985) Sialylation of glycoprotein oligosaccharides with N-acetyl-, N-glycolyl-, and N-O-diacetyl-neuraminic acids. J. Biol. Chem. 260 88388849.
  • 19
    Higashi H., Hirabayashi Y., Fukui Y., Naiki M., Matsumoto M., Ueda S., Kato S. (1985) Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer. Cancer Res. 45 37963802.
  • 20
    Hirabayashi Y., Higashi H., Kato S., Taniguchi M., Matsumoto M. (1987a) Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas. Jpn. J. Cancer Res. 78 614620.
  • 21
    Hirabayashi Y., Kasakura H., Matsumoto M., Higashi H., Kato S., Kasai N., Naiki M. (1987b) Specific expression of unusual GM2 ganglioside with Hanganutziu-Deicher antigen activity on human colon cancers. Jpn. J. Cancer Res. 78 251260.
  • 22
    Hirabayashi Y., Hyogo A., Nakao T., Tsuchiya K., Suzuki Y., Matsumoto M., Kon K., Ando S. (1990) Isolation and characterization of extremely minor gangliosides, GM1b and GD1α, in adult bovine brains as developmentally regulated antigens. J. Biol. Chem. 265 81448151.
  • 23
    Hof L. & Faillard H. (1973) The serum dependence of the occurrence of N-glycolylneuraminic acid in HeLa cells. Biochim. Biophys. Acta 297 561563.
  • 24
    Irie A. & Suzuki A. (1998) CMP-N-acetylneuraminic acid hydroxylase is exclusively inactive in humans. Biochem. Biophys. Res. Commun. 248 330333.DOI: 10.1006/bbrc.1998.8946
  • 25
    Irie R.F. & Morton D.L. (1986) Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc. Natl. Acad. Sci. USA 83 86948698.
  • 26
    Jeanloz R.W. & Codington J.F. (1976) Biological role of sialic acid at the cell surface, in Biological Roles of Sialic Acid (Rosenberg A. and Schengrung C.-L., eds), pp. 201238. Plenum, New York.
  • 27
    Joshi P.G. & Mishra S. (1992) Galactocerebroside mediates Ca2+ signaling in cultured glioma cells. Brain Res. 597 108113.
  • 28
    Kawai T., Kato A., Higashi H., Kato S., Naiki M. (1991) Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res. 51 12421246.
  • 29
    Kawashima I., Ozawa H., Kotani M., Suzuki M., Kawano T., Gomibuchi M., Tai T. (1993) Characterization of ganglioside expression in human melanoma cells: immunological and biochemical analysis. J. Biochem. (Tokyo) 114 186193.
  • 30
    Kean E.L. (1966) Separation of gluco- and galactocerebrosides by means of borate thin-layer chromatography. J. Lipid Res. 7 449452.
  • 31
    Kean E.L. (1991) Sialic acid activation. Glycobiology 1 441447.
  • 32
    Kennedy P.G., Watkins B.A., Thomas D.G., Noble M.D. (1987) Antigenic expression by cells derived from human gliomas does not correlate with morphological classification. Neuropathol. Appl. Neurobiol. 13 327347.
  • 33
    Louis J.C., Magal E., Muir D., Manthorpe M., Varon S. (1992) CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J. Neurosci. Res. 31 193204.
  • 34
    Mansson J.E., Fredman P., Bigner D.D., Molin K., Rosengren B., Friedman H.S., Svennerholm L. (1986) Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line. FEBS Lett. 201 109113.
  • 35
    Marquina G., Waki H., Fernandez L.E., Kon K., Carr A., Valiente O., Perez R., Ando S. (1996) Gangliosides expressed in human breast cancer. Cancer Res. 56 51655171.
  • 36
    Miyake M., Hashimoto K., Ito M., Ogawa O., Arai E., Hitomi S., Kannagi R. (1990) The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. A study with specific monoclonal antibodies. Cancer 65 499505.
  • 37
    Muchmore E.A., Milewski M., Varki A., Diaz S. (1989) Biosynthesis of N-glycolylneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool. J. Biol. Chem. 264 2021620223.
  • 38
    Murray J.L., Cunningham J.E., Brewer H., Mujoo K., Zukiwski A.A., Podoloff D.A., Kasi L.P., Bhadkamkar V., Fritsche H.A., Benjamin R.S. , et al., (1994) Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors. J. Clin. Oncol. 12 184193.
  • 39
    Murray J.L., Kleinerman E.S., Jia S.F., Rosenblum M.G., Eton O., Buzaid A., Legha S., Ross M.I., Thompson L., Mujoo K., Rieger P.T., Saleh M., Khazaeli M.B., Vadhan Raj S. (1996) Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma. J. Immunother. Emph. Tumor Immunol. 19 206217.
  • 40
    Nishinaka Y., Ravindranath M.H., Irie R.F. (1996) Development of a human monoclonal antibody to ganglioside G(M2) with potential for cancer treatment. Cancer Res. 56 56665671.
  • 41
    Ohashi Y., Sasabe T., Nishida T., Nishi Y., Higashi H. (1983) Hanganutziu-Deicher heterophile antigen in human retinoblastoma cells. Am. J. Ophthalmol. 96 321325.
  • 42
    Ponten J. & Macintyre E.H. (1968) Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74 465486.
  • 43
    Schauer R. (1985) Sialic acids and their roles as biological masks. Trends Biochem. Sci. 10 357360.
  • 44
    Schauer R. (1988) Sialic acids as antigenic determinants of complex carbohydrates. Adv. Exp. Med. Biol. 228 4772.
  • 45
    Sekine M., Ariga T., Miyatake T., Kase R., Suzuki H., Yamakawa T. (1984) Gangliosides and neutral glycolipids in guinea pig adrenal glands. J. Biochem. (Tokyo) 96 237244.
  • 46
    Seyfried T.N. & Ariga T. (1992) Neutral glycolipid abnormalities in a t-complex mutant mouse embryo. Biochem. Genet. 30 557565.
  • 47
    Seyfried T.N., Ando S., Yu R.K. (1978a) Isolation and characterization of human liver hematoside. J. Lipid Res. 19 538543.
  • 48
    Seyfried T.N., Glaser G.H., Yu R.K. (1978b) Cerebral, cerebellar, and brain stem gangliosides in mice susceptible to audiogenic seizures. J. Neurochem. 31 2127.
  • 49
    Seyfried T.N., Yu R.K., Saito M., Albert M. (1987) Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 47 35383542.
  • 50
    Seyfried T.N., El-Abbadi M., Roy M.L. (1992) Ganglioside distribution in murine neural tumors. Mol. Chem. Neuropathol. 17 147167.
  • 51
    Seyfried T.N., Novikov A.M., Irvine R.A., Brigande J.V. (1994) Ganglioside biosynthesis in mouse embryos: sialyltransferase IV and the asialo pathway. J. Lipid Res. 35 9931001.
  • 52
    Seyfried T.N., El-Abbadi M., Ecsedy J.A., Bai H.W., Yohe H. (1996) Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem. 66 20262033.
  • 53
    Seyfried T.N., El-Abbadi M., Ecsedy J.A., Griffin M.E., Yohe H.C. (1998) Ganglioside composition of a mouse brain tumor grown in the severe combined immunodeficiency (SCID) mouse. Mol. Chem. Neuropathol. 33 2737.
  • 54
    Suetake K., Tsuchihashi K., Inaba K., Chiba M., Ibayashi Y., Hashi K., Gasa S. (1995) Novel modification of ceramide: rat glioma ganglioside GM3 having 3-O-acetylated sphingenine. FEBS Lett. 361 201205.
  • 55
    Sung C.C., Pearl D.K., Coons S.W., Scheithauer B.W., Johnson P.C., Yates A.J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 74 30103022.
  • 56
    Suzuki Y., Suzuki N., Michi H., Matsumoto M. (1985) Characterization of gangliosides of porcine erythrocyte membranes: occurrence of ganglioside GD3 as major ganglioside. Lipids 20 588593.
  • 57
    Uttenreuther Fischer M.M., Huang C.S., Yu A.L. (1995) Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a Phase I trial in neuroblastoma patients. Cancer Immunol. Immunother. 41 331338.DOI: 10.1007/s002620050236
  • 58
    Varki A. (1997) Sialic acids as ligands in recognition phenomena. FASEB J. 11 248255.
  • 59
    Westphal M., Brunken M., Rohde E., Herrmann H.D. (1988) Growth factors in cultured human glioma cells: differential effects of FGF, EGF and PDGF. Cancer Lett. 38 283296.
  • 60
    Wikstrand C.J., Fredman P., McLendon R.R., Svennerholm L., Bigner D.D. (1994a) Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Mol. Chem. Neuropathol. 21 129138.
  • 61
    Wikstrand C.J., Fredman P., Svennerholm L., Bigner D.D. (1994b) Detection of glioma-associated gangliosides GM2, GD2, GD3, 3′-isoLM1 3′,6′-isoLD1 in central nervous system tumors in vitro and in vivo using epitope-defined monoclonal antibodies. Prog. Brain Res. 101 213223.
  • 62
    Yu R.K. & Ledeen R.W. (1970) Gas-liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species. J. Lipid Res. 11 506516.